What we found on the web about Squibb
Bristol-Myers Squibb - Wikipedia, the free encyclopedia
Bristol-Myers Squibb (NYSE: BMY), colloquially referred to as BMS, is a pharmaceutical company. Founded in 1887 by William McLaren Bristol and John Ripley Myers in Clinton, NY ...
E. R. Squibb - Wikipedia, the free encyclopedia
Edward Robinson Squibb (1819-1900) was a leading American inventor and manufacturer of pharmaceutics who founded E. R. Squibb and Sons, which eventually became part of the modern ...
Squibb Show | Old Time Radio
ABOUT THIS OLD TIME RADIO SHOW: All text on OTRCAT.com are ©2007 OTRCAT INC - All Rights Reserved. Reproduction is prohibited. "To your good health, from the House of Squibb!"
Squibb Demolition
company Squibb Demolition Limited. Squibb Demolition Limited is one of the UK’s leading demolition contractors offering a comprehensive service for all demolition ...
Squibb Estates Custom Homes in Denver
Squibb Estates is a custom homebuilder of the highest quality luxury residences. Our residential designs unite the strength of architectural excellence with the beauty of ...
BMS | Patient Assistance Foundation
The Bristol-Myers Squibb Patient Assistance Foundation, Inc. is a non-profit organization. The Foundation was established in 1998 to provide temporary assistance to qualifying ...
index.jpg
A.M. Squibb has been providing schools with class record and lesson plan books for over one hundred years. But did you know we can customize your own student assignment planner ...
Hamilton & Squibb, LLP - Legal Services for the Energy and Real-Estate ...
Hamilton & Squibb, LLP, was founded by Rhodes W. Hamilton and Clifton A. Squibb with an emphasis on oil-and-gas and real-property law. Primarily representing clients in the energy ...
Entry added by Creative Administrator
Creative Administrator also edited:
Here is what users have to say about Squibb

Bristol-Myers Squibb (nyse: BMY), colloquially referred to as BMS, is a pharmaceutical company. Founded in 1887 by William McLaren Bristol and John Ripley Myers in Clinton, NY (both were graduates of Hamilton College), Bristol-Myers merged with Squibb Corporation in 1989. James M. Cornelius is the New York City-based company's Chairman and CEO.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention Squibb
Midday Glance: Pharmaceuticals companies
AP via Yahoo! Finance
NEW YORK (AP) -- Shares of some top pharmaceuticals companies are mixed at noon: Baxter rose $.09 or .2 percent, to $55.40. Bristol-Myers Squibb fell $.31 or 1.4 percent, to $22.38. Hospira rose $.05 or .1 percent, to $45.94. Johnson & John...
This IPO Is Hot, Baby
Motley Fool
Baby formula maker Mead Johnson (NYSE: MJN ) went public this morning, snatched from the womb of parent Bristol-Myers Squibb (NYSE: BMY ) and displayed to the cheering masses. The company behind Enfamil infant formula priced its IPO at $24 ...
On the Discovery Trail
New York Times
Working in the antiviral chemistry division at Bristol-Myers Squibb, I was in charge of overseeing the science for the drug stavudine for H.I.V., and when we developed tenofovir disoproxil fumarate it replaced stavudine. I joined Gilead Sci...
Exelixis Announces October 29 Webcast of Third Quarter 2009 Financial ...
PR Inside
Exelixis has established strategic corporate alliances with major pharmaceutical and biotechnology companies, including Bristol-Myers Squibb, sanofi-aventis, GlaxoSmithKline, Genentech, Boehringer Ingelheim, Wyeth Pharmaceuticals, and Daiic...
Bristol-Myers posts higher 3Q sales, lower profit
San Francisco Chronicle
Drugmaker Bristol-Myers Squibb Co. on Thursday reported a solid increase in third-quarter revenue, due to strong sales growth for its blockbuster blood thinner Plavix and other key medicines, and boosted its profit forecast. Higher average ...
Bristol-Myers’ Profit Rises, Tops Analyst Estimates (Update4)
Bloomberg
Oct. 22 (Bloomberg) -- Bristol-Myers Squibb Co. raised its earnings forecast for the year after third-quarter profit rose 64 percent on lower costs and higher sales of its blood thinner Plavix and mood stabilizer Abilify.
Bristol-Myers posts higher 3Q sales, lower profit
AP via Yahoo! News
Drugmaker Bristol-Myers Squibb Co. on Thursday reported a solid increase in third-quarter revenue, due to strong sales growth for its blockbuster blood thinner Plavix and other key medicines, and boosted its profit forecast.
Vanda shares rise after signs deal with Novartis
Reuters
By Toni Clarke BOSTON (Reuters) - Shares of Vanda Pharmaceuticals Inc (VNDA.O) rose 7.3 percent on Tuesday after Swiss drug ... Johnson & Johnson (JNJ.N) Quote, Profile, Research Bristol-Myers Squibb Company (BMY.N) Quote, Profile, Research
Bristol-Myers Squibb presents study data on ORENCIA for treating rheumatoid arthritis
News-Medical-Net
Bristol-Myers Squibb Company today announced two-year results of a study that supports use of ORENCIA® (abatacept) for methotrexate-naive patients with moderate to severe rheumatoid arthritis of less than or equal to two years duration.
A. Collier Smyth joins Ariad board
Mass High Tech
Cambridge oncology therapies firm Ariad Pharmaceuticals Inc. has named former Bristol-Myers Squibb Co. (BMS) senior vice president of medical strategy A. Collier Smyth to its board of directors. Smyth announced his retirement from BMS last ...
Zacks Analyst Blog Highlights: Facet Biotech Corporation, Biogen Idec ...
MSN Money
Stocks recently featured in the blog include: Facet Biotech Corporation (Nasdaq: FACT), Biogen Idec Inc. (Nasdaq: BIIB), Trubion Pharmaceuticals (Nasdaq: TRBN), Bristol-Myers Squibb (NYSE: BMY) and Acorda Therapeutics ...
Final Glance: Pharmaceuticals companies
AP via Yahoo! Finance
NEW YORK (AP) -- Shares of some top pharmaceuticals companies were mixed at the close of trading: Baxter rose $.28 or .5 percent, to $55.59. Bristol-Myers Squibb fell $.23 or 1.0 percent, to $22.46. Hospira rose $.22 or .5 percent, to $46.1...